US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 475 actively recruiting studies with Ohio sites out of 475 registered in total. The busiest research areas in Ohio are Ovarian Cancer, Solid Tumor, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, The Cleveland Clinic, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (96), Phase 2 (140), Phase 3 (106), Phase 4 (16).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
475
Recruiting Now
475
← Back to US Map
Top Conditions in Ohio
Ovarian Cancer (9)Solid Tumor (8)Advanced Solid Tumor (8)Heart Failure (7)Colorectal Cancer (7)Prostate Cancer (7)Schizophrenia (7)Acute Myeloid Leukemia (6)Advanced Solid Tumors (6)Chronic Lymphocytic Leukemia (6)Multiple Myeloma (5)Metastatic Castration-resistant Prostate Cancer (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 475 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 475. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Ovarian Cancer, Solid Tumor, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
View Trial →
NCT01401998 N/A
Recruiting
ARPKD Database Study
Condition
Hepato/Renal Fibrocystic Disease
Enrollment
200 pts
Location
United States
Sponsor
Children's Hospital of Philade
View Trial →
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06121011 N/A
Recruiting
A Global Prospective Observational Registry of Patients With Pompe Disease
Condition
Pompe Disease
Enrollment
500 pts
Location
United States, Austria, Belgium
Sponsor
Amicus Therapeutics
View Trial →
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT07266831 Phase 2, Phase 3
Recruiting
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have No...
Condition
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Enrollment
570 pts
Location
United States, Argentina, Canada
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07225439 Phase 1
Recruiting
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatm...
Condition
Non Hodgkin Lymphoma
Enrollment
15 pts
Location
United States
Sponsor
Paolo Caimi, MD
View Trial →
NCT02964494 N/A
Recruiting
The Congenital Dyserythropoietic Anemia Registry (CDAR)
Condition
Congenital Dyserythropoietic Anemia (CDA)
Enrollment
10,000 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT07061951 Phase 2
Recruiting
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Rel...
Condition
Recurrent Chronic Lymphocytic Leukemia
Enrollment
20 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05446272 N/A
Recruiting
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Condition
Extubation Failure
Enrollment
478 pts
Location
United States, Canada
Sponsor
University of Pennsylvania
View Trial →
NCT07231705 N/A
Recruiting
Growth and Tolerance of Plant-based Enteral Formulas in Children Ages 12-17 Mont...
Condition
Formula Dependent Children 1 to 2 Years of Age
Enrollment
40 pts
Location
United States
Sponsor
Kate Farms Inc
View Trial →
NCT06263231 Phase 3
Recruiting
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US...
Condition
Sarcoma,Soft Tissue
Enrollment
333 pts
Location
United States, Canada, France
Sponsor
Intensity Therapeutics, Inc.
View Trial →
NCT04929288 N/A
Recruiting
Neural and Hormonal Influences on Sex Differences in Risk for AUD
Condition
Alcohol Use Disorder
Enrollment
100 pts
Location
United States
Sponsor
Jessica Weafer
View Trial →
NCT05490888 Phase 1
Recruiting
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirr...
Condition
Cirrhosis, Liver
Enrollment
74 pts
Location
United States
Sponsor
PharmaIN
View Trial →
NCT05867251 Phase 1, Phase 2
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
430 pts
Location
United States, Australia
Sponsor
Avenzo Therapeutics, Inc.
View Trial →
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therap...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
473 pts
Location
United States, Australia, Canada
Sponsor
Bicara Therapeutics
View Trial →
NCT06095505 Phase 2
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Condition
Small Cell Lung Cancer
Enrollment
120 pts
Location
United States
Sponsor
Puma Biotechnology, Inc.
View Trial →
NCT05654922 Phase 3
Recruiting
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progress...
Condition
Pre-Bronchiolitis Obliterans Syndrome
Enrollment
100 pts
Location
United States
Sponsor
Renovion, Inc.
View Trial →
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,700 pts
Location
United States, Austria, Czechia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05218083 N/A
Recruiting
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program W...
Condition
COVID-19
Enrollment
120 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT07003542 Phase 2
Recruiting
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive ...
Condition
Glioblastoma
Enrollment
48 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT07586618 Phase 1
Recruiting
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Har...
Condition
Lymphoblastic Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Allterum Therapeutics, Inc
View Trial →
Page 2 of 19 — 475 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology